Transgender Awareness Week falls between November 12-19 every year and is meant to help raise visibility of a vulnerable and underserved community. ‘Transgender’ is an umbrella term for people whose gender identity is different from the sex assigned at birth; ‘gender identity’ is one’s innermost concept of self as male, female, a blend of both, or neither. Transgender and gender-nonconforming people can face significant problems with accessing health care. Finding a healthcare provider who is knowledgeable of transgender health issues can be a hurdle itself; some healthcare professionals may believe that there is something wrong with someone because they are […]
Category: Healthcare Reform
ACA Open Enrollment
The Affordable Care Act (ACA; aka Obamacare) Health Insurance Marketplace begins its sixth Open Enrollment period today. American healthcare consumers can sign up on the federal insurance exchange at healthcare.gov or through their state marketplaces. Last year there was increased confusion surrounding Open Enrollment due to changes (and attempted changes) made to the ACA under the Trump administration, leading to the U.S. uninsured rate to rise for the first time since 2014 and the largest single-year increase since 2008. Open Enrollment period ran 90 days after November 1 until the end of January during the Obama administration but was cut […]
Trump’s Speech on Drug Prices Boosts Pharmaceutical Stocks
President Donald Trump gave a speech about pharmaceutical drug prices last month. During his presidential campaign and leading up to his inauguration, he accused pharmaceutical companies with “getting away with murder” for what they charge patients for prescriptions and promised to enact reforms to lower drug prices. After sixteen months in office, his speech last month consisted of few proposals as opposed to proposing meaningful legislation or guidelines that could have an immediate effect on prescription costs and actually led to pharmaceutical stocks rising. Trump took aim at Pharmacy Benefit Managers (PBMs) who he referred to as “middlemen” who […]
Getting out of the Weeds with Medicinal Cannabis
Medicinal cannabis (aka medical marijuana) is a growing topic in the United States. Today, there are 29 states (plus Washington DC) where cannabis is a legal medical option for patients. Cannabis is mostly prescribed for pain relief but can also be used to treat muscle spasms caused by multiple sclerosis, chemotherapy-induced nausea, lack of appetite from chronic illness, seizure disorders, Crohn’s disease, and more. However, cannabis exists in a legal gray area: while medicinally legal in a majority states, it is federally illegal and considered a Schedule I controlled substance by the Drug Enforcement Agency (DEA)—defined as having no acceptable […]
Laws Proposed to Protect Patients from Artificially High Prescription Costs
In a previous blog post, we explored “clawback” and how it affects the prices of prescriptions. In short, Pharmacy Benefit Managers (PBMs) negotiate copay prices for insurers that are often higher than the cash price paid by uninsured patients all while instituting a “gag rule” for pharmacists to forbid them from revealing the price discrepancy to patients unless asked directly. A number of states have already passed laws banning clawback and gag rules, though a group of bipartisan U.S. senators have introduced a bill the ban gag clauses for PBM-negotiated contracts nationwide. A recent study by Journal of the American […]